Orchestra BioMed Inc. (OBIO)
NASDAQ: OBIO
· Real-Time Price · USD
3.00
-0.36 (-10.71%)
At close: Jun 18, 2025, 3:59 PM
3.13
4.51%
After-hours: Jun 18, 2025, 04:27 PM EDT
-10.71% (1D)
| Bid | 3 |
| Market Cap | 114.75M |
| Revenue (ttm) | 2.89M |
| Net Income (ttm) | -66.32M |
| EPS (ttm) | -1.77 |
| PE Ratio (ttm) | -1.69 |
| Forward PE | -1.9 |
| Analyst | Buy |
| Ask | 3.32 |
| Volume | 623,811 |
| Avg. Volume (20D) | 408,071 |
| Open | 3.44 |
| Previous Close | 3.36 |
| Day's Range | 2.91 - 3.44 |
| 52-Week Range | 2.37 - 8.87 |
| Beta | 0.63 |
About OBIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OBIO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for OBIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+10.94%
Orchestra BioMed shares are trading higher after t...
Unlock content with
Pro Subscription
1 month ago
+0.7%
Orchestra BioMed shares are trading higher after the company announced it secured FDA Breakthrough Device Designation for AVIM therapy.
3 weeks ago · seekingalpha.com
Orchestra BioMed: Two Best-In-Class Devices And Promising PartnershipsOrchestra BioMed holds two best-in-class medical device therapies targeting large markets, with strong partnerships and equity investments from Medtronic and Terumo. Both AVIM Therapy and Virtue SAB h...
